What if Hemophilic Joint Damage Isn’t as Irreversible as We Thought? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Parthiv Sheth et al, adding:
“What if hemophilic joint damage isn’t as irreversible as we thought?
For decades, hemophilic arthropathy has been viewed as a one-way path: bleed to damage, damage to progression.
This new longitudinal ultrasound study challenges that narrative.
Using the JADE musculoskeletal ultrasound protocol, researchers followed adults with hemophilia for up to 3 years and tracked cartilage, bone, and soft-tissue changes across elbows, knees, and ankles.
Here’s the surprising part։
- Joint tissues showed dynamic plasticity over time
- Some unhealthy joints actually showed signs of repair
- Hemarthrosis was linked to cartilage thinning and increased PRO-C4 biomarker turnover
- PRO-C4 may signal ongoing synovial vascular remodeling and subclinical bleeding
- Clinical scores barely changed — while ultrasound detected subclinical tissue trajectories
Translation:
- We may finally have tools to see joint biology evolving in real time — not just the end-stage damage.
This work reframes hemophilic arthropathy as a dynamic, remodeling disease, opening the door to earlier intervention, better monitoring, and new outcome measures for trials.”
Tilte: Joint tissue plasticity in hemophilia: insights from the Joint Activity and Damage Exam ultrasound protocol
Authors: Parthiv Sheth, Khang Tong, Bilgimol Chumappumkal Joseph, Tina Manon-Jensen, Michael Glenzer, Isaac Nwi-Mozu, Peter Aguero, Bruno Steiner, Cindy Bailey, Doris V. Quon, Rebecca Kruse-Jarres, Euyhyun Lee, Morten Asser Karsdal, Lin Liu, Annette von Drygalski
Read the Full Article on RPTH Journal.

Find more posts featuring RPTH Journal on Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines